• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Massachusetts Eye and Ear Infirmary (MEEI)

Massachusetts Eye and Ear® clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. Now united with Schepens Eye Research Institute, Massachusetts Eye and Ear® is the world’s largest vision and hearing research center, developing new treatments and cures through discovery and innovation. Massachusetts Eye and Ear® is a Harvard Medical School teaching hospital and trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Massachusetts Eye and Ear® employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. In the 2016–2017 “Best Hospitals Survey”, U.S. News & World Report ranked Massachusetts Eye and Ear® #1 in the nation for ear, nose and throat care and #1 in New England for eye care. *

 

Please contact us with your proposals. Thank you!

	Start	1824-01-01 established
	Group	Harvard University
	Industry	hospitals
	Industry 2	medicine
	Region	Boston, MA
	Country	United States (USA)
	Street	243 Charles Street
	City	02114 Boston, MA
	Tel	+1-617-523-7900
		Address record changed: 2013-10-29
Basic data	Employees	n. a.
		* Document for �About Section�: Lonza Group Ltd.. (9/12/16). "Press Release: Lonza to Offer Novel Anc-AAV Gene Therapy Technology Through Exclusive Licensing Agreement with Massachusetts Eye and Ear". Basel & Boston, MA.
		Record changed: 2018-10-31

Advertisement

More documents for Harvard University

• [1] Bruker Corporation. (5/9/18). "Press Release: 2018 Laukien Prize Winner Announcement"....
• [2] Cellectis S.A.. (5/1/18). "Press Release: Harvard’s Wyss Institute Partners with Cellectis to Recode the Human Genome". Boston, MA & New York, NY....
• [3] Bruker Corporation. (4/30/18). "Press Release: Bruker Introduces New NMR Technologies and Research Products". Orlando, FL....
• [4] Novartis AG. (3/20/18). "Press Release: Novartis Teams Up with Harvard to Develop Next Generation Biomaterial Systems to Deliver Immunotherapies". Basel....
• [5] Helmholtz-Zentrum München. (12/22/17). "Press Release: Launch of Helmholtz Center Munich’s Stem Cell Center"....
• [6] ProQR Therapeutics N.V.. (11/9/17). "Press Release: ProQR Appoints Thaddeus Dryja, M.D., to Scientific Advisory Board". Leiden....
• [7] Servier. (10/19/17). "Press Release: Servier Establishes Strategic Research Alliance with Harvard University"....
• [8] Genenta Science S.r.l.. (9/13/17). "Press Release: Genenta Raised Other $8,4 Million (€7 Million) in the Second Round of Financing - Total Raised in Two Rounds, $20,4 Million (€17 Million) -". Milano....
• [9] Compugen Ltd.. (5/25/17). "Press Release: Compugen Announces Appointment of Dr. Michal Preminger to Board of Directors". Holon....
• [10] Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2019. Made in Germany.